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Abstract: Herbal medicine is a clinical practice of utilizing medicinal plant derivatives for therapeutic
purposes. It has an enduring history worldwide and plays a significant role in the fight against
various diseases. Herbal drug combinations often exhibit synergistic therapeutic action compared
with single-constituent dosage, and can also enhance the cytotoxicity induced by chemotherapeutic
drugs. To explore the mechanism underlying the pharmacological action of herbs, proteomic
approaches have been applied to the physiology of medicinal plants and its effects on animals.
This review article focuses on the existing proteomics-based medicinal plant research and discusses
the following topics: (i) plant metabolic pathways that synthesize an array of bioactive compounds;
(ii) pharmacological action of plants tested using in vivo and in vitro studies; and (iii) the application
of proteomic approaches to indigenous plants with scarce sequence information. The accumulation
of proteomic information in a biological or medicinal context may help in formulating the effective
use of medicinal plants.
Keywords: proteomics; medicinal plants; metabolic pathway; pharmacological action; accessibility
to sequence data; access and benefit-sharing
1. Introduction
Medicinal plants have been the long-standing backbone of herbalism worldwide and are an
important part of biomedical innovation. Many therapeutic drugs used in conventional medicine
were discovered on the basis of traditional knowledge of medicinal herbs, and were developed
through multidisciplinary scientific validation [1]. One of the most important drug discoveries is
the highly effective anticancer drug paclitaxel, which is naturally derived from Taxus brevifolia [2].
Although extensive screening of plant-derived natural products is underway, a vast number of plant
components that can be promising drug sources remain unidentified [3]. Identifying such active
compounds is difficult owing to multi-class secondary metabolites and the complex biosynthesis of
these metabolites [4]. Biosynthesis of secondary metabolites is the summation of plant genetics and
physiological responses to environmental factors. Considerable differences in the makeup of bioactive
compounds such as flavonoids and saponins have been reported in a single species [5,6]. Moreover,
most of the bioactive compounds in medicinal plants are extensively modified by chemical reactions.
Multiple glycosylation steps form branch points within the biosynthetic pathways and lead to the
production of diverse subfamilies of compounds with diverse drug-related properties [7,8]. Therefore,
the understanding of the metabolic networks in medicinal plants and their systemic regulation is
crucial for the future identification of active compounds.
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Practical application of new drugs requires precise understanding of pharmacological properties
of the compounds for their optimal use in clinical practice. Much attention has been paid to publishing
scientific evidence for the effectiveness of plant-derived natural products [9]. In cancer therapy,
various drug target pathways have been identified, including cyclin-mediated cell proliferation [10],
p53-dependent apoptosis [11], and cytotoxicity accompanied with autophagy [12]. In addition to
these pleiotropic antitumor effects, plant-derived products such as scutellarin, which is a type of
flavone, can potentiate the effect of antitumor cytotoxic drugs, such as cisplatin [13]. Such herb–drug
interactions can affect the outcome of pharmacotherapy in both favorable and unfavorable directions
by influencing the enzymatic activity of drug metabolism in the body [14]. Furthermore, the occurrence
of synergistic effects between compounds has been shown using different combinations of bioactive
compounds isolated from Citrus sinensis [15]. The effect of mixed crude extracts from three herbs
was also evaluated for potentiated effects [16]. One component in a multi-herbal formula may be
identified as the active principle, but the mixture may include ingredients that cause potentiating or
antagonistic effects, which are crucial for assessing the formula’s pharmacological action. Elucidating
the mechanism underlying the pleiotropic action of herbal combinations can help understand the
synergy between compounds and assist in developing suitable drugs with negligible adverse effects.
The complexity of drug discovery based on plant products requires a highly integrated approach
with respect to medicinal plant science. In this regard, a proteomic approach for medicinal plant
research is described in the following section to elucidate plant metabolic pathways that synthesize
bioactive compounds. The subsequent section deals with responses of cultured cells and animal models
treated with plant-derived bioactive compounds and extracts to understand the pharmacological action
of the plants. In the final section, we surveyed an emerging field of proteomic application to indigenous
plants in tropical regions. Accessibility to sequence data plays a key role in promoting the potential
scientific value of indigenous and underutilized plants.
2. Plant Metabolic Pathways that Synthesize an Array of Bioactive Compounds
Plants utilize their metabolic systems for the biosynthesis of a wide variety of bioactive compounds
to adapt to challenging ecosystems [17]. The metabolism of these compounds is influenced by plant
genetics and environmental factors (Figure 1). Therefore, the composition and amount of bioactive
compounds can exhibit intra- and inter-species variation [5,18]. Biological changes along with plant
growth or in response to environmental stresses have been clarified in major crop species using
proteomic techniques [19,20]. Proteins specifically relevant to the control of metabolic pathways
accelerate the development of new cultivars. An example of this is folate-biofortified rice, which has
provided health benefits in the developing world [21]. Metabolic engineering of multiple genes such
as GTP cyclohydrolase, ADC synthase, together with either folylpolyglutamate synthase or folate-binding
protein has been successfully implemented and has increased the folate content in folate-biofortified
rice by over 100-fold than in non-engineered rice [22]. The introduction of genes of folate-synthesizing
enzymes and folate-stabilizing factors enhances the folate content; this highlights the importance of
requirement of thorough knowledge of the regulation of the endogenous metabolic pathways.
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Figure 1. Overview of proteomic contribution to medicinal plant research. Proteomic technique, 
combined with other omics approaches, can shed light on both physiological aspects of plant 
secondary metabolism in response to environmental factors and pharmacological action of plant-
derived active compounds on animals. 
Proteomic techniques, which enable the measurement of systemic changes during cellular 
metabolism, have been used to analyze the synthesis of bioactive compounds that confer to medicinal 
plants their health promoting properties (Figure 1) [23]. Cannabis sativa, or the marijuana plant, is 
often used to reduce chronic pain [24]. Comparative proteomics was applied to identify specific 
tissue-expressed proteins of C. sativa because cannabinoids, the major active compounds of the plant, 
are found in many parts of the plant such as glands, flowers, and leaves [25]. Panax ginseng is a 
perennial herb that is used to treat physiological disorders such as diabetes, heart disease, cancer, 
and neurodegeneration [26]. The active components in ginseng include ginsenosides, a class of 
triterpene saponins that are found almost exclusively in Panax spp. [27]. Because the cultivation of 
ginseng is challenging owing to its long-life cycle [28], understanding the biosynthetic pathways of 
ginsenosides becomes crucial [29]. The metabolic changes along with plant growth were elucidated 
using proteomic analysis, revealing that ginseng roots initiate ginsenoside biosynthesis when the 
plant reaches a slow-growth period [30]. Such changes in root physiology demonstrate the early 
activity of enzymes that mediate upstream processes within the ginsenoside biosynthesis network 
and upregulation of enzymes that mediate downstream processes in later stage [31]. Recent 
proteomic analysis of a type of ginseng cultivar that grows slower than wildtype ginseng revealed 
that the cultivar increases ginsenoside biosynthesis as the plant ages [32]. The correlation of changes 
in energy metabolism with ginsenoside content was revealed by metabolic profiling [33]. In addition 
to traditionally used roots, the medicinal values of ginseng fruits were evaluated using proteomics 
[23]. A correlation between the abundance of the 6-phosphogluconate dehydrogenase family protein 
and radical scavenging activity of ginseng fruits was revealed by comparing different cultivars [23]. 
The results show the usefulness of proteomic techniques to discover key enzymes that are crucial for 
biological activities of medicinal plants.  
Improved and accurate identification of proteins via proteomics is available for various 
medicinal plants [34]. Jointly used with RNA sequencing, isobaric tags for relative and absolute 
Figure 1. Overview of proteomic contribution to medicinal plant research. Proteomic technique,
combined with other omics approaches, can shed light on both physiological aspects of plant secondary
metabolism in response to environmental factors and pharmacological action of plant-derived active
compounds on animals.
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Improved and accurate identification of proteins via proteomics is available for various
medicinal plants [34]. Jointly used with RNA sequencing, isobaric tags for relative and absolute
protein quantitation (iTRAQ) helped identify four proteins belonging to the CYP718A subfamily of
enzymes in Anemone flaccida that are essential for triterpenoid saponin biosynthesis [35]. The choice
of sequence database is important for biosynthetic pathway analysis, as is indicated by a report that
ascertained a series of enzymes playing a role in the final stages of artemisinin biosynthesis in Artemisia
annua [36]. A metabolomic approach is another tool for the analysis of biosynthetic pathways
for useful phytochemicals in plants [37]. Metabolomic analysis of Salvia miltiorrhiza, a perennial
herb belonging to the Lamiaceae family, revealed differences of secondary metabolite profiles among
several genotypes and phenotypes [38,39]. A wide array of secondary metabolites is synthesized
through specific metabolic pathways that are often triggered by environmental stresses. A series
of reports focusing on the effect of ultraviolet (UV) irradiation found that UV-A treatment of Taxus
chinensis, a medicinal herb used against cancer, activated a photosynthetic reaction [40], and that
the enhanced glycolysis provided precursors for secondary metabolism [40]. UV-B treatment of
Clematis terniflora, which is a source of antitumor drugs, demonstrated the accumulation of indole
alkaloids [41], upregulation of flavonoid biosynthesis [42], and increased γ-aminobutyric acid
levels [43]. Enhanced flow of amino acids into the secondary metabolic pathways was shown by
proteomic identification of enzymes like S-adenosylmethionine synthase and cysteine synthase [43].
Metabolic content in medicinal plants was improved by changes in abundance in 10-hydroxygeraniol
oxidoreductase in Catharanthus roseus [44], or 1-deoxy-d-xylulose 5-phosphate reductoisomerase and
5-enol-pyruvylshikimate-phosphate synthase in Lonicera japonica [45]. UV-B irradiation can also
cause the reduction of allergic compounds such as ginkgolic acids in Ginkgo biloba [46]. For the
proteomic analysis of secondary metabolism in medicinal plants, purification of proteins that are low
in abundance by application of combinatorial peptide ligand libraries (CPLL) or polyethylene glycol
fractionation treatment was established as effective [45,47].
Agricultural proteomics is important in identifying useful plant cultivars, molecular mechanisms
that underlie desirable physiological traits of the cultivars, and the response of plant cells to
environmental stresses (Figure 1) [48]. For medicinal plants, these strategies are also effective in
unraveling secondary metabolism networks and novel enzymes that remain unexplored (Figure 1).
3. Pharmacological Action of Plants Tested Using In Vivo and In Vitro Studies
Traditional medicine uses medicinal plants to treat chronic heterogeneous disorders worldwide,
especially in developing countries [49]. As the population ages in developed countries, self-medication
using herbal remedies has become a choice for promoting healthier living [50]. However, despite
the long history of effective use of medicinal plants, many of them remain untested for efficacy and
safety. In terms of identifying and evaluating active components in the extracts of medicinal plants,
the beneficial and adverse effects of isolated compounds require to be tested against cultured cell lines
(Figure 1).
Proteomics has been used to study cellular responses to bioactive compounds such as
oridonin, a diterpenoid from Rabdosia rubrescens; curdione, a sesqiterpenoid from Cucurma aromatica;
and geniposide, an iridoid glycoside from Gardinia jasmonoides [51–53]. Findings of a two-dimensional
electrophoresis study identified stathmin as a target of R. rubrescens-derived oridonin in human
hepatocarcinoma cells [51]. Because stathmin is a strong prognostic biomarker of poor survival in
non-small cell lung cancer [54], oridinin has important implications in cancer therapy. With respect
to antithrombotic activities of C. aromatica, proteins that are responsible for focal adhesion such
as talin 1 and beta-1 tubulin were identified by gel-free proteomic techniques in curdione-treated
human platelets, clarifying the molecular mechanism of action by G. jasmonoides [52]. For the detection of
adverse side effects, biomarkers were searched for in geniposide overdose-induced hepatic injuries in rat
model [53]. Using the intensity-based absolute quantification (iBAQ) method, glycine N-methyltransferase
and glycogen phosphorylase were found to induce hepatotoxicity during the initial stages [53].
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Subproteome-capturing technology unraveled how energy metabolism imbalance is caused in
mitochondria to exert the anticancer activity of dihydroartemisinin from Artemisia annua [55].
Understanding of cellular responses is promoted by proteomic analyses in various cultured cell
lines and animal models that are treated with natural products from medicinal plants.
It is increasingly evident that crude plant extracts containing complex mixtures of compounds
often show greater activity than isolated constituents at an equivalent dose [56]. One report emphasized
that total saponins are the active components of Achyranthes aspera, which can neutralize bone
degeneration caused by rheumatoid arthritis in rats [57]. Total flavonoids isolated from Scutellaria
baicalensis water extract show antimicrobial, antiviral, anti-inflammatory, and antitumor effects by
inhibiting NF-κB signaling [58,59]. Moreover, studies that focused on the immunomodulatory effect
of Vigna radiata water extract demonstrated that total flavonoids but not one of the flavonoids in the
extract has the biological activity in murine cells [60]. Neither synthetic vitexin, which is the major
flavonoid in V. radiata, nor its derivative can modulate interleukin-6 expression, but the removal of
total flavonoids diminishes the effect of the extract on interleukin-6 expression [60]. Crude extract
of V. radiata has a protective pleiotropic effect in mice against sepsis [61]. The pleiotropic effect was
revealed to be caused by the plant’s ability of both immunosuppressing the acute inflammation and
promoting antigen processing/presentation [60]. The search for its active main compound is under
progress, but information regarding the composition of the V. radiata extract is present. Bioactive
compounds such as prostaglandins and their biosynthetic pathways were identified in the species [5].
The comprehensiveness of proteomic profiling allowed the elucidation of the complex biological
processes occurring in mice treated with medicinal plant extracts (Figure 1).
A traditional Chinese medicine prescription called Buyang Huanwu decoction, composed of
seven kinds of medicinal plants, is used for treating cerebral ischemic stroke-induced disability [62].
It was shown to suppress the release of glutamate [63], increase the abundance of synapse-related
proteins, and maintain the synaptic ultrastructure in cerebral ischemic rats [64]. The biological reaction
against the treatment was elucidated by iTRAQ-based proteomic analysis [65]. In the mouse stroke
model, the levels of proteins associated with stroke responses increased, including blood–brain barrier
breakdown and enhanced excitotoxicity, but they were restored after treatment with the herb mixture.
Functional profiling showed that the herb mixture treatment rescued disturbed energy metabolism
and increased the neurogenesis marker doublecortin [65]. The report also showed the multiple
effects of medicinal plants on ischemic stroke including the protective role and recovery against
injury [65]. Buzhong Yiqi is a herbal formula used for treating various conditions [66] such as muscle
atrophy, whereby the decoction can downregulate nuclear receptor corepressor 1 and its downstream
factors [67]. Mitochondrial oxidative metabolism was identified as the mechanism underlying the
Buzhong Yiqi-mediated recovery of muscle quantity [67]. Furthermore, the therapeutic mechanism
underlying Shufeng Jiedu comprises eight medicinal herbs, and AKT1 kinase was considered as
a key factor in acute lung injury [68]. The hypothesis from proteomic data was proved by gain-
and loss-of-function analyses of macrophages, displaying that AKT1-mediated biological processes,
including oxidative stress, apoptosis, and inflammatory responses were involved in acute lung
injury [68]. Most medicinal plants are used for treating different symptoms. The identification of target
pathways by proteomic profiling explains the various applications in heterogeneous disorders and will
help improve the treatment regimen (Figure 1). On the other hand, efforts have been made to identify
active compounds in the extracts of medicinal plants and validate their functionality. Narrowing the
candidate list of active main compounds will also be possible using the identified pathways that are
affected by the treatment as markers of physiological responses.
4. Application of Proteomics to Indigenous Plants
Plants that became the focus of attention of the above scientific studies were commercialized
species. A protein catalogue was provided for the mango plant, which is a leading fruit crop
and produces the unique xanthonoid called mangiferin [69,70]. A recent study improved protein
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purification methods for extracting proteins existing in small quantity in mango fruit pulp and
banana [71,72]. In addition to the popular plants, some of the indigenous and underutilized plants
were analyzed for their phytochemicals and physiology [73]. Proteomic profiles of plants such as
Nigella sativa, Moringa oleifera, and Pseudostellaria heterophylla that are used in traditional medicine
have been published [74–76]. Protein extraction was optimized for seagrass species Zostera muelleri
and Posidonia australis, which contain hundreds of bioactive compounds and are used as cosmetic
additives [77,78]. Proteomics is used for the efficacy evaluation of epigenetic intervention of carotenoid
biosynthesis in Zingiber zerumbet, a tropical plant used as a tonic and a stimulant [79]. Contribution of
proteomic techniques to medicinal plant science is not limited to elucidate the systemic changes in
physiology; it is also used for isolating key enzymes in useful compound production. Centella asiatica
is a herb used in Asian countries, which has become popular in the rest of the world [80,81]. Saponins
are the active compounds in this plant that are modified by multiple glycosylation. In the search
for saponin glucosyltransferases in C. asiatica, a successfully isolated enzyme was the triterpenoid
carboxylic acid: UDP-glucose 28-O-glucosyltransferase [82]. Many unique enzymes and metabolic
pathways can be discovered by appropriate application of proteomic techniques.
Constraints associated with medicinal plant studies include the complexity of plant secondary
metabolism, which is often unique to the species, and the lack of genomic information. Genome
sequences have been provided for some species [83,84], but as the basis for secondary metabolism
studies, transcriptomic analysis is of growing importance (Figure 1) [85]. RNA sequencing-based
transcriptomic data are now available for medicinal plants such as Dendrobium officinale [86], Dioscorea
nipponica [87], Ephedra sinica [88], L. japonica [89], and Polygonum minus [90]. Not only medicinal
plants, but also other tropical plants, were studied by RNA sequencing-based transcriptomic
analysis with an eye for understanding the unique characteristics of diverse plants such as pitcher
plants [91,92]. The high throughput sequences obtained using RNA sequencing are archived in public
data repositories such as the sequence read archive so that the data can be reanalyzed [93].
Data sharing and comparison are crucial for promoting scientific work in the biological sciences.
Today, over 4400 research activities are supported by the research infrastructure Kyoto Encyclopedia
of Genes and Genomes (KEGG), which provides cross-organismal annotation of genes [94]. However,
there is concern for open-access utilization of high throughput sequences from the viewpoint of
access and benefit-sharing (ABS), which refers to the rules governing the use of genetic resources and
associated traditional knowledge. Attention must be paid to the international rules and appropriate
access to genetic resources to promote responsible conduct of medicinal plant research.
5. Conclusions
Medicinal plants are a potential source of new drugs and therapeutics. However, many natural
products and biosynthetic pathways, which can be promising sources for medical applications,
remain unidentified. Pharmacological activities of many medicinal plants are not fully elucidated.
Two directions for future research on medicinal plants, which are plant physiological studies especially
on secondary metabolism and pharmacological actions of plant-derived compounds on animals
(Figure 1), are necessary for proper and sustainable utilization of plant genetic resources and
their metabolic products. Proteomics offers the advantage of collating a comprehensive collection
of physiological information both from medicinal plants and animals that consume the plants.
The identification of key enzymes has helped elucidate the multistep, complicated biosynthetic
pathways of plant bioactive compounds. External factors that affect the pathways and the physiological
changes caused by the factors are described using the proteomic analyses of plants. Responses of
the animals treated with plant-derived natural products were shown to include various biological
processes. These studies are two sides of the same coin in research on medicinal plants. Combining
these research disciplines by increasing instances of multidisciplinary collaborative research that
involve researchers from both fields would help promote research on medicinal plants.
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